Whitepaper: Isolation of tumour infiltrating lymphocytes from dissociated tumour cells

Discover how BioIVT’s dissociated tumour cells (DTCs) can be used for tumour-infiltrating lymphocyte (TIL) cell therapy research.

Tumour-infiltrating lymphocytes, or TILs, hold promise as the basis for solid tumour cell therapies. While sourcing them for research has proven be logistically challenging when they’re derived from fresh tumour tissue, BioIVT’s dissociated tumour cell (DTC) product line may be the answer.

In this white paper, you will learn about what TILs are and their therapeutic applications, the characterization of BioIVT’s donor pool by TIL content and a review of the frequency of TILs by tumour tissue type.